Octopus AIM VCT PLC

Octopus AIM VCT PLC

OOA.L
Octopus AIM VCT PLCGB flagLondon Stock Exchange
39.80
GBp
- -
- -
99.37MMarket Cap
Octopus AIM VCT PLC
OOA.L
(London Stock Exchange)

Recent

price

39.80

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
- -
- -
-0.01
0.12
0.36
-0.08
0.02
0.18
0.07
-0.11
0.01
0.36
-0.12
-0.19
-0.09
-0.02
Revenue per Share
0.01
- -
-0.02
0.11
0.35
-0.08
0.01
0.17
0.06
-0.11
0.01
0.36
-0.12
-0.19
-0.09
-0.03
Basic EPS, GAAP
0.03
-0.01
-0.02
-0.01
-0.02
- -
0.01
0.06
-0.09
-0.02
-0.01
-0.02
-0.02
-0.02
- -
- -
Free Cash Flow per Basic Share
0.05
0.05
0.05
0.05
0.05
0.05
0.09
0.04
0.05
0.04
0.07
0.04
0.07
0.04
0.04
0.08
Dividend per Share
0.53
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Book Value per Share
0.76
1.06
0.84
0.9
1.29
1.18
1.03
1.13
1.23
1.03
0.91
1.28
1.07
0.82
0.67
0.53
Tangible Book Value per Share
31
37
47
49
54
62
75
89
103
119
126
142
158
173
194
219
Basic Weighted Avg Shares
- -
- -
-1
6
19
-5
1
16
7
-13
2
52
-19
-33
-17
-5
Sales/Revenue/Turnover
- -
- -
-9.43
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
-1
5
19
-5
1
15
6
-13
1
51
-19
-33
-18
-6
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
141.96
95.93
98.64
108.69
61.94
97.27
91.52
104.58
60.93
98.63
104.15
102.11
103.99
112.01
Profit Margin (%)
7
11
9
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
24
39
40
44
70
73
77
100
127
123
115
182
168
141
129
115
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
1.47
-2.12
-99.81
988.44
3,776.73
-868.83
104.8
1,852.17
658.46
-1,135.41
81.08
3,773.65
-1,269.34
-1,963.8
-924.61
-281.44
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.86%
3.07%
-10.63%
Free Cash Flow
-36.72%
-31.92%
-142.37%
Net Income, GAAP
620.37%
969.36%
-65.72%
Sales/Revenue/Turnover
351.81%
577.95%
-68.18%
Total Cash Common Dividend
29.56%
25.61%
117.84%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
-17
2025
- -
- -
- -
- -
-5
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
-0.09
2025
- -
- -
- -
- -
-0.03
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.04
2025
- -
- -
- -
- -
0.08
2026
- -
- -
- -
- -
- -
Business
Octopus AIM VCT plc (OOA.L) is a United Kingdom-based venture capital trust that invests in a diversified portfolio of qualifying companies listed on the Alternative Investment Market (AIM) or Aquis Stock Exchange (AQSE), targeting attractive tax-free dividends and long-term capital growth for shareholders. Founded in 1997 and headquartered at 33 Holborn in London, the company, managed by Octopus Investments Limited, holds approximately 74 investments across sectors including software and computer services; pharmaceuticals and biotechnology; electronic and electrical equipment; construction and materials; investment banking and brokerage services; industrial materials; telecommunications service providers; medical equipment and services; retail; healthcare; data analytics; and identity intelligence, with notable holdings such as Sosandar, Craneware, Diaceutics and GB Group. It primarily serves experienced investors seeking exposure to established, maturing UK growth businesses, with around 80 combined holdings in Octopus AIM VCTs generating net assets of roughly £114 million as of late 2025 and a targeted 6% annual dividend yield. Recent developments include a £20 million prospectus fundraise launched in September 2024 alongside Octopus AIM VCT 2 plc, which closed fully subscribed in March 2025 after raising £12.6 million net for OOA; follow-on investments in portfolio companies such as £1.1 million in Abingdon Health plc for laboratory expansion, £0.5 million in Cambridge Cognition Holdings plc for commercial strategy execution, and £0.5 million in GENinCode plc for genomic testing; and new investments including £1.1 million in Aurrigo International plc for aviation autonomous vehicles. The trust maintains a focus on profitable, dividend-paying companies, with 67% of holdings profitable as of mid-2025, while navigating AIM market volatility through selective deal flow from IPOs and existing positions.